BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 205 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2019. The put-call ratio across all filers is 1.21 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $23,195,467 | +94.6% | 529,456 | +183.7% | 0.05% | +126.1% |
| Q1 2022 | $11,921,000 | -88.3% | 186,600 | -80.4% | 0.02% | -87.8% |
| Q4 2021 | $101,827,000 | +3553.6% | 950,682 | +3407.4% | 0.19% | +1466.7% |
| Q3 2021 | $2,787,000 | -18.9% | 27,105 | -30.7% | 0.01% | -25.0% |
| Q2 2021 | $3,438,000 | +742.6% | 39,086 | +973.2% | 0.02% | +700.0% |
| Q4 2020 | $408,000 | -98.3% | 3,642 | -98.6% | 0.00% | -98.7% |
| Q3 2020 | $24,186,000 | +1255.7% | 260,902 | +1041.3% | 0.16% | +1191.7% |
| Q2 2020 | $1,784,000 | -85.5% | 22,860 | -89.2% | 0.01% | -90.2% |
| Q1 2020 | $12,340,000 | +2131.5% | 211,006 | +2956.7% | 0.12% | +2975.0% |
| Q4 2019 | $553,000 | +18.7% | 6,903 | -20.1% | 0.00% | -20.0% |
| Q4 2018 | $466,000 | -98.0% | 8,635 | -97.1% | 0.01% | -94.9% |
| Q3 2018 | $23,158,000 | +2624.5% | 296,668 | +879.0% | 0.10% | +1550.0% |
| Q4 2016 | $850,000 | – | 30,302 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |